chrisvoncsefalvay/vaers-outcomes huggingface dataset:
it is scaly; dry patch on his arm  that went from the elbow to the base of the armpit; This spontaneous case was reported by a consumer and describes the occurrence of EXFOLIATIVE RASH (it is scaly) and RASH (dry patch on his arm  that went from the elbow to the base of the armpit) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced EXFOLIATIVE RASH (it is scaly) and RASH (dry patch on his arm  that went from the elbow to the base of the armpit). At the time of the report, EXFOLIATIVE RASH (it is scaly) and RASH (dry patch on his arm  that went from the elbow to the base of the armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Presyncopal event - upon laying back & juice felt better w/in 10 minutes. That evening fever to 102 degrees, arthralgia, sick feeling.
Pt given expired ACTHIB, mother notified, provider checking o pt. daily as now no s/s of reaction. Report completed for MMRV as well on 10-12-17.
itchy; redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (redness) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (redness). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 UNK. At the time of the report, VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Other treatment details included alcohol.
Swelling in left arm, arm pit and left breast as well as extreme pain in these areas. I was unable to stand up on my own. I had extreme pain in all my joints. I had a migraine for 24 hours that was excruciating. I had a high fever. This was a terrible experience. This all lasted for 24 hours. Ive never been in this type of pain, all over my body.
A 3.5 inch diameter knot/welt on my right arm (did not happen at all with first shot).  The knot in my arm was red, painful and extremely itchy.  I also have increased dizziness, sensitivity to light, headaches and cloudiness, extreme fatigue, right shoulder joint and right side of neck stiffness (hard to move); Did not go to Flight Doc; at last visit with first reaction, was told that any further reactions will not be treated, I would simply be put on DNIF (quaters).  I figured a trip would be useless.  I simply am suffering through work.
Developed sore throat on March 3, then had negative strep test.  Sore throat persisted and saw ENT with normal exam.  Lost sense of smell and taste on March 7th.  Negative Covid test on March 10.  Developed swelling in left leg on March 9, and had ultrasound on March 10 that showed DVT.  Was hospitalized on March 10 and had second negative Covid test by PCR.
She had injection on tuesday here in her R arm.  she noted some reaction that started a little that night and then more on wednesday wiht redness and spreading. it does not itchin, no exudate or pus from shot/injection side.  she did put some ice on it and took tylenol.  she has not had a fever, no chills.  no nausea or vomit.  no diarrhea.  she has less appetite.
Rashes appear then disappear after a few hours, comes and goes.; Rashes all over body; 4 days after 2nd shot started getting skin reaction; burning sensation; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18May2021 at 15:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN), iron (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), collagen (MANUFACTURER UNKNOWN) and melatonin (MANUFACTURER UNKNOWN) from unknown date for unspecified indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 18:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22May2021, four days after the vaccination, the patient experienced a skin reaction that looked like scratch marks and occasionally in random blotches all over the body (rash all over), including legs, arms, stomach, back, neck, and face, rashes appeared then disappeared after a few hours, comes and goes. On an unknown date of May2021, after a week after onset of rashes, the patient experienced burning sensation from rashes. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. The clinical outcome of the events rash all over body, legs arms, stomach back, neck, face and rashes started burning sensation was not recovered at the time of this report.  The batch/lot numbers for BNT162b2, were not provided and will be requested during follow up.
Immediately: sharp pain in lower back, arm pits, and neck.  Hours later: numb limbs, clumsy hands/fingers  One week later: rash on the back of thighs   After three weeks: rash covered most of thighs, calfs, and near under arms.  Was so severe walking was painful.  Visited doctor for rash at three weeks: was prescribed Pepcid AC, Benadryl, and Xyzal.  I took one Pepcid and one Xyzal for 4 days and the rash went away almost completely.   I stopped taking them because I got a cold. Now I use topical Benadryl for my rash, which only comes back when it is hot and humid outside.  I'm only saying I didn't recover because my rash comes back every once in a while even after taking the pills.  I never had a rash that painful in my life.  The biggest rash I ever had before Gardasil was a couple little red bumps from grass irritation that went away in just minutes. 10/13/09 Medical Records received for Date of Service 8/12/08. Dx:  UTI, Plantar wart, inguinal hernia First Gardasil shot given.
I felt like I had covid again. Tired, mental fog, body aches. I had to go back on my O2 machine. I had Covid 11/26/2020.
approx 12hr p/vax pt devel low grade temp 101, stomach ache, irritability, arms hurt @ inj site, nausea, 21hrs p/vomiting x 1, temp, joint pains;lt arm hurt more than rt;
Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022; Received vaccine past its 30-days Exp date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2022 at 2:17 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 11-Mar-2022 at 2:17 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided by the reporter.  It was reported that the vaccine went into 2-8 C thaw state on or about 24-Dec-2021 and the patient received booster dose on 11-Mar-2022 at 02:17:07 PM.   No treatment information was reported.    This case was linked to MOD-2022-542869 (Patient Link).
Irregular Menstrual Period: short cycle (15-22 days), heavier than typical period pre-vaccine, prolonged period (12 days), no treatment given Extreme Fatigue: Sleeping 8-9 hours and can barely function through a typical day, irritable Frequent headaches lasting multiple days
Information has been received from a registered nurse concerning a 43 day old female with no pertinent medical history or drug allergies who on 28-JAN-2008 was vaccinated PO with her first 2.0 ml dose of ROTATEQ (lot# 659688/1620U). Concomitant vaccinations administered on that same day included a dose of ACTHIB and a dose of PREVNAR. Shortly after vaccination the same day, the patient experienced diarrhea. The infant's mother called the physician's office on 31-JAN-2008 to mention that the diarrhea was continuing and the patient was then seen by the physician. The patient was treated with fluids, PEDIALYTE with weight monitoring and her formula was switched to DF, an infant formula. On 06-FEB-2008 the patient was seen in the office again for diarrhea that continued 10 days after vaccination. The patient was gradually reintroduced to her usual formula after the diarrhea resolved and she was recovered on 10-FEB-2008. There was no product quality complaint. Additional information has been requested.
immunization with stored vial vaccine more than 30 days from time it was used; Arm soreness; joint ache; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (immunization with stored vial vaccine more than 30 days from time it was used), PAIN IN EXTREMITY (Arm soreness) and ARTHRALGIA (joint ache) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 025520-2A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (immunization with stored vial vaccine more than 30 days from time it was used), PAIN IN EXTREMITY (Arm soreness) and ARTHRALGIA (joint ache). At the time of the report, EXPIRED PRODUCT ADMINISTERED (immunization with stored vial vaccine more than 30 days from time it was used), PAIN IN EXTREMITY (Arm soreness) and ARTHRALGIA (joint ache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
It was reported that a pt received Fluzone '97-'98 on 10/26/98 and some time, post vax, the pt experienced uncontrollable movement of the left arm and shoulder. The pt was seen by the reporting physician and treated with Haldol. The pt was also seen by a neurologist who continued Haldol treatments.  Follow up #1 19-Jun-2002:  During internal review of all files, it was deemed necessary to amend the report by updating the Adverse Event coding (deleted tremor).
This case was reported by a pharmacist via call center representative and described the occurrence of pain in a male patient who received TWINRIX adult (batch number 3EX72, expiry date 22nd March 2016). On 3rd March 2015 09:30, the patient received TWINRIX adult (injection) 1 ml. On 5th March 2015, 2 days after receiving TWINRIX adult, the patient experienced pain and pins and needles. On an unknown date, the outcome of the pain and pins and needles were unknown. The reporter considered the pain and pins and needles to be related to TWINRIX adult. Additional information: The patient's right arm was sore, he felt like he had pins and needles in his right pectoral muscle and he had an elevated blood pressure and pulse.
Irritable in 24 hours. Low grade fever - Tylenol given small bumps
facial swelling, itching, redness right forarm, tingling of lips and face; tongue swelling Narrative:  This is a 54-year-old female with history of significant for sleep apnea, chronic obstructive lung disease, fibromyalgia, and previous allergies to 3 medications, milk and shellfish. The patient received her first dose of Moderna Covid-19 vaccine on 2/26/21. The patient apparently reported itching within 10 minutes and within 20 minutes she developed mild lips and tongue swelling. No breathing difficulty noted. The patient reported taking Benadryl liquid with relief of her symptoms. No Epi Pen was administered. On 3/3/21, the patient was seen by the Immunologist for evaluation as the patient requested to receive her second dose despite potential risk for another allergic reaction. The immunologist recommended to patient's primary care provider to premedicate the patient 1 hour prior to 2nd dose of Moderna with specific instructions for the vaccine to be administered at the Emergency Department. Another option was for the patient not to get the second dose of Moderna and wait for a different vaccine. The patient informed her primary care provider that she wants the 2nd dose administered. On 3/26/21, the patient premedicated herself as instructed from home with fexofenadine 180mg, diphenhydramine 50mg, famotidine 40mg, and prednisone 20mg prior to her 2nd dose of the vaccine. Patient received her second dose of Moderna Covid-19 vaccine around 3:09 pm at the Emergency Department (ED) area. After 15 minutes, the patient had facial swelling and was immediately given Epi Pen in left thigh. Patient was checked in to the ED. Thirty minutes later, the patient experienced itching and redness in her right forearm, headaches, tingling of her lips and face, then found her tongue swelling with difficulty opening her mouth. The patient received her 2nd dose of the Epi Pen in addition to diphenhydramine IV and IV methylprednisolone (steroid). She was later transferred to MICU for further monitoring due to potential airway compromise. The patient was admitted to MICU on 3/26/21. Covid-19 negative. She was transferred to acute care ward on 3/27/21 for additional monitoring of her angioedema. As of 3/29/21, the patient is in a stable condition. Per hospitalist, patient's facial swelling has gradually improved and remains on iv steroid treatment. If the patient is able to tolerate oral steroid and her symptoms continues to improve, the patient will be discharged if patient remains stable.
p/vax pt devel numbness in lt hand (middle fingers);progressed up arm to neck/back shoulder blade;tx pred, cortisone;insomnia, SOB;vicodin;cont pain; Annual follow-up dated 1/31/01 states that the pt has been diagnosed with brachial plexus neuropathy and that she suffers from a permanent partial disability.
She was in bed/ not doing so hot/ knocked down in bed for two days; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (She was in bed/ not doing so hot/ knocked down in bed for two days) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Sep-2021, the patient experienced BEDRIDDEN (She was in bed/ not doing so hot/ knocked down in bed for two days). At the time of the report, BEDRIDDEN (She was in bed/ not doing so hot/ knocked down in bed for two days) outcome was unknown.            No concomitant was reported. No treatment was reported.   This case was linked to MOD-2021-314558 (Patient Link).
Developed hives covering stomach & chest, knees, back of knees, some on back as well. Spoke with her Dr immediately and gave Benadryl upon Dr's recommendation. Hives subsided. However, next morning (10/15) some new hives had developed on face & knees. Not nearly as severe, though. Administered Benadryl again.
No additional adverse effect reported; Nurse reported administration ofROTATEQ after temperature excursion; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medication were not reported.  On 23-JUL-2020, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 2 milliliter, orally, lot # 1676324 has been verified to be a valid lot number, expiration date 21-APR-2020 (frequency was not provided) for prophylaxis.   The the vaccine was stored in 8 Celsius degrees (C) (8.83 C) for 20 hours. There were no previous excursions reported. The storage was recorded by digital data logger. No adverse effects were reported.
Patient became agitated. Began running fever. Fever 102.1 Thursday, Friday high as 104, Saturday high of 103, Sunday 102. Treated with infant acetaminophen during day and ibuprofen at night.  Temp normal on 10/07/13, rash started. Saw doctor 10/07/13 and was diagnosed with Roseola.
48 patients received an expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (48 patients received an expired vaccine) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (48 patients received an expired vaccine). On 16-Nov-2021, EXPIRED PRODUCT ADMINISTERED (48 patients received an expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Pfizer-BioNTech COVID-10 Vaccine EUA.  After receiving the first dose of Pfizer vaccine, patient experienced lightheadedness. This occurred within a couple minutes after administration of vaccine. VS include BP 116/63, P 84, O2 100%. Cetirizine 10mg PO administered at 1535. Patient felt comfortable with no additional or worsening symptoms upon leaving clinic.
Day 1: fever to 100 Day 2: lnner ear feeling of instability Day 3: Lower extremity weakness and unstable gait Day 4: Sent to ER-CVA identified
The soreness in my arm developed about 6 hours after receiving vaccine. The next afternoon 3/9/2019 at about 2:30 pm I started to feel very lethargic to the point I had to lay down to take a nap. Slept about 4 hours. When I woke up I felt better, no lethargy but the soreness in my arm was getting worse. I also noticed it was very red and swollen around injection site. I went out  to dinner that evening but started developing a low grade fever during dinner. I felt better by the next day, no actual symptoms other than my arm was red a swollen for another 6 days.
pt recv vax & exp extreme irritability, nausea, chest pain & tingling in hand; devel swollen lymph glands; No further details were provided;
For 72 hours after my injection, I had a sore throat, fever, chills and totally lethargic. Now on Day 3, the injection site is still red, warm and sore.
Immediate metal  taste under tongue. Tingling of tongue , lips and mouth . Immediate  heart racing.  Numbness of face, tongue and mounts left side and around eye. Similar to feeling after a novocaine injection at the dentist.  Severe shivers and muscle shakes approximately 20 minutes after especially in left leg. Still feel slight tingling and strange feeling in mouth three hours later.
Information has been received from a Doctor of Pharmacy concerning a 73 year old male patient with pre-hypertension, hyperlipidaemia, disc degeneration, allergy to DARVON and a history of myalgia with simvastatin (MSD, WAES 1003USA01423) and LIPITOR, who on 01-MAR-2010, was vaccinated intramuscularly with a dose of PNEUMOVAX (lot number 663999/0624Y). Concomitant therapy included fish oil and red rice yeast pills. It was stated that the patient reported to his physician that he probably had not received PNEUMOVAX vaccine in the past. Two days later the patient saw the physician and reported left upper extremity redness and soreness that began on the night of 01-MAR-2010, and got progressive worse. The patient also reported that he might have received PNEUMOVAX vaccine before, prior to 01-MAR-2010. The physician gave DEPO-MEDROL 40 mg for 1 dose, ROCEPHIM 1 g 1 dose, KEFLEX 500 mg four times a day for 7 days and over the counter BENADRYL to resolve the adverse event. The adverse event resolved on 05-MAR-2010. No laboratory diagnostic studies were performed. Upon internal review left upper extremity redness and soreness was considered to be an other important medical event. Additional information has been requested.
Patient experienced a red, inflamed area around the sight of injection.  It was 1 inch by 2 inches, was raised, warm, and itched.  She started loratidine on 3/25/16. On 3/26/16 she went to the ER and was given a prescription for KEFLEX and BENADRYL. The rash was gone by 4/4/2016.
Janssen COVID-19 Vaccine EUA. 7 days after shot I have the worst headache/migraine. I have gone to Er for CT scans that show clear so no blog clots. I do not have a history of migraines.  I am unable to move. Work. Do anything. This is day 2. Idk how I'm to get thru this!!
This spontaneous report as received from a consumer refers to a 11 year old female patient with no pertinent medical history, drug reactions or allergies. The patient was vaccinated with dose 1 and dose 2 of  (oka/merck) VARIVAX (lot #, dose and route not reported) when she was younger on an unspecified date and was accidentally vaccinated with a third dose of (oka/merck) VARIVAX (lot #, dose and route not reported) on 10-OCT-2012. No other co-suspects were reported. Concomitant medications included MENACTRA (unspecified), tetanus toxoid (manufacturer unspecified). The patient's mother reported that on 10-OCT-2012 her daughter's arms hurt but other than that there were no other adverse reactions. The mother stated that the patient had two shots in her right arm and one shot in her left arm. The patient sought medical attention by calling the physician. The patient was given TYLENOL as treatment for the event and no lab diagnostic tests were performed. The outcome of arms hurt was reported as recovering. The relatedness for arms hurt was not provided for (Oka/Merck) VARIVAX. Additional information is not expected.
Patient experienced swelling in a gland on her neck on the left side and increased blood pressure. Patient went to the emergency room where she was monitored and then released. The swelling and blood pressure has now reduced. Patient stated that they were unsure if it was an issue with her thyroid, the flu shot, or an allergic reaction to something she ate (she stated she was eating blueberries and cherry tomatoes).